Cargando…

Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes

BACKGROUND: PLCγ enzymes are key nodes in cellular signal transduction and their mutated and rare variants have been recently implicated in development of a range of diseases with unmet need including cancer, complex immune disorders, inflammation and neurodegenerative diseases. However, molecular n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Bunney, Tom D., Khosa, Sakshi, Macé, Kévin, Beckenbauer, Katharina, Askwith, Trevor, Maslen, Sarah, Stubbs, Christopher, de Oliveira, Taiana M., Sader, Kasim, Skehel, Mark, Gavin, Anne-Claude, Phillips, Christopher, Katan, Matilda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000336/ https://www.ncbi.nlm.nih.gov/pubmed/31918402 http://dx.doi.org/10.1016/j.ebiom.2019.102607

Ejemplares similares

Characterization of the membrane interactions of phospholipase Cγ reveals key features of the active enzyme
por: Le Huray, Kyle I. P., et al.
Publicado: (2022)

Structural and Functional Integration of the PLCγ Interaction Domains Critical for Regulatory Mechanisms and Signaling Deregulation
por: Bunney, Tom D., et al.
Publicado: (2012)

Rac Regulates Its Effector Phospholipase Cγ(2) through Interaction with a Split Pleckstrin Homology Domain
por: Walliser, Claudia, et al.
Publicado: (2008)

Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
por: Magno, Lorenza, et al.
Publicado: (2019)

Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations
por: Lima, Nadia Carvalho, et al.
Publicado: (2020)

Time-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLCγ1
por: Perdios, Louis, et al.
Publicado: (2016)

Dynamic Allostery in PLCγ1 and Its Modulation by a Cancer Mutation Revealed by MD Simulation and NMR
por: Koss, Hans, et al.
Publicado: (2018)

Crystal Structure of the Human, FIC-Domain Containing Protein HYPE and Implications for Its Functions
por: Bunney, Tom D., et al.
Publicado: (2014)

NMR backbone assignments of the tyrosine kinase domain of human fibroblast growth factor receptor 3 in apo state and in complex with inhibitor PD173074
por: Sanfelice, Domenico, et al.
Publicado: (2018)

Phospholipase C Isozymes Are Deregulated in Colorectal Cancer – Insights Gained from Gene Set Enrichment Analysis of the Transcriptome
por: Danielsen, Stine A., et al.
Publicado: (2011)

Notch signaling deregulation in multiple myeloma: A rational molecular target
por: Colombo, Michela, et al.
Publicado: (2015)

Phospholipase C-gamma 1 association with CD3 structure in T cells
Publicado: (1992)

Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane
por: Katan, Matilda, et al.
Publicado: (2020)

CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex
por: van Maldegem, Febe, et al.
Publicado: (2015)

Activation of the Endonuclease that Defines mRNA 3′ Ends Requires Incorporation into an 8-Subunit Core Cleavage and Polyadenylation Factor Complex
por: Hill, Chris H., et al.
Publicado: (2019)

Conformational transition of FGFR kinase activation revealed by site-specific unnatural amino acid reporter and single molecule FRET
por: Perdios, Louis, et al.
Publicado: (2017)

Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System
por: Bunney, Tom D., et al.
Publicado: (2018)

Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation
Publicado: (1992)

Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
por: Katan, Mira, et al.
Publicado: (2014)

Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells
Publicado: (1992)

The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study
por: Bunney, Tom D., et al.
Publicado: (2015)

BANK1 and BLK Act through Phospholipase C Gamma 2 in B-Cell Signaling
por: Bernal-Quirós, Manuel, et al.
Publicado: (2013)

Uncapping and Deregulation of Telomeres Lead to Detrimental Cellular Consequences in Yeast
por: Smith, Christopher D., et al.
Publicado: (1999)

A bipartite structural organization defines the SERINC family of HIV-1 restriction factors
por: Pye, Valerie E., et al.
Publicado: (2020)

Association of the tyrosine kinase LCK with phospholipase C-gamma 1 after stimulation of the T cell antigen receptor
Publicado: (1992)

Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis
Publicado: (1995)

Chromatin deregulation in disease
por: Mirabella, Anne C., et al.
Publicado: (2015)

Molecular basis of APC/C regulation by the spindle assembly checkpoint
por: Alfieri, Claudio, et al.
Publicado: (2016)

Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2022)

Protein Defense Systems against the Lantibiotic Nisin: Function of the Immunity Protein NisI and the Resistance Protein NSR
por: Khosa, Sakshi, et al.
Publicado: (2016)

Preparation of monoclonal antibodies against gamma-type phospholipase A(2) inhibitors and immunodetection of these proteins in snake blood
por: Li, Jingjing, et al.
Publicado: (2017)

Epigenetic gene deregulation in cancer
por: Malik, K, et al.
Publicado: (2000)

Questioning coal ash deregulation.
por: Tenenbaum, D J
Publicado: (2000)

Electricity economics: regulation and deregulation
por: Rothwell, Geoffrey S, et al.
Publicado: (2003)

Deregulation of Rho GTPases in cancer
por: Porter, Andrew P., et al.
Publicado: (2016)

Apoptosis deregulation in myeloproliferative neoplasms
por: Tognon, Raquel, et al.
Publicado: (2013)

Deregulation of Transcriptional Enhancers in Cancer
por: Mirzadeh Azad, Fatemeh, et al.
Publicado: (2021)

Epigenetic Deregulation of Apoptosis in Cancers
por: Ozyerli-Goknar, Ezgi, et al.
Publicado: (2021)

Metabolic Deregulation in Pulmonary Hypertension
por: Mathew, Rajamma, et al.
Publicado: (2023)

Plk1 and CK2 Act in Concert to Regulate Rad51 during DNA Double Strand Break Repair
por: Yata, Keiko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fjbrmv8c6hscao183sjvg79l3n